Mortality Reduction Associated with Coexistent Antithrombotic Use in Nursing Home Residents with COVID-19

J Am Med Dir Assoc. 2022 Mar;23(3):440-441. doi: 10.1016/j.jamda.2021.11.012. Epub 2021 Nov 19.

Authors

Laurent Adler¹, Cathy Lipton¹, Clay C Watson¹, Shanieek Lawrence², Alexa Richie², Clare Spain³, Kevin Heltemes³

Affiliations

¹ Complex Care Management, Optum Inc, United Health Group, Eden Prairie, MN, USA.
² Optum Center for Research and Innovation, Optum Inc, UnitedHealth Group, Eden Prairie, MN, USA.
³ Health Care Economics, Optum Inc, United Health Group, Eden Prairie, MN, USA.

No abstract available

Publication types

Letter

MeSH terms

Aged
COVID-19*
Fibrinolytic Agents* / therapeutic use
Homes for the Aged
Humans
Nursing Homes
SARS-CoV-2

Substances

Fibrinolytic Agents